Collaboration Agreement under which the company commercializes Amgen oncology products in China and the parties share profits and losses equally
| Officer | Age | In this role | Source |
|---|---|---|---|
|
John V. Oyler
Also a director
Co-Founder, Chairman and Chief Executive Officer
|
58 | Not stated | |
|
Aaron Rosenberg
Chief Financial Officer
|
Not stated |
Since 2024
2 years
|
|
|
Xiaobin Wu
President and Chief Operating Officer
|
Not stated | Not stated | |
|
Chan Lee
Senior Vice President, General Counsel and Corporate Secretary
|
Not stated |
Since 2022
4 years
|
|
|
Lai Wang
President, Global Head of R&D
Title from the Form 4 dated Jun 23, 2026
|
Not stated | Not stated | |
|
Titus B. Ball
Principal Accounting Officer
Title from the Form 4 dated Nov 6, 2026
|
Not stated | Not stated |
Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.
Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.
Collaboration Agreement under which the company commercializes Amgen oncology products in China and the parties share profits and losses equally
Global oncology pipeline collaboration with co-funding of development costs, with BeOne Switzerland contributing up to US$1.25 billion
Share Purchase Agreement under which the company issued 206,635,013 ordinary shares (15,895,001 ADSs) to Amgen
Sublease of property in San Carlos, California from an Amgen affiliate for research facilities and office space
Exclusive license agreement for BAITUOWEI in mainland China with upfront license payment and prepayment
Joint venture through BeiGene Shanghai with capital contributions by BeOne HK and Cayman Gaoyue
Service agreement for construction project due diligence and project management services, with extension
Share repurchase of all BeiGene Shanghai shares held by Cayman Gaoyue
Consulting agreement providing for an annual fixed consulting fee
Master services agreement, statements of work and subscription agreement with Pi Health for FICS implementation and clinical services, with payments totaling US$52,000,000
Subscription and services agreement with Pi Health USA, LLC with an annual fee
BeOne Medicines I GmbH preferred stock purchase in Pi Health Series Seed funding, with a further investment contingent on milestones
Order forms under master services agreement for data analytics support services provided by Constellation
Loading...